No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder

Pharmacoepigenetic studies are important to understand the mechanisms through which medications influence the developing fetus. For instance, we and others have reported associations between prenatal paracetamol exposure and offspring DNA methylation (DNAm). Additionally, folic acid (FA) intake duri...

Full description

Bibliographic Details
Main Authors: Emilie Willoch Olstad, Hedvig Marie Egeland Nordeng, Robert Lyle, Kristina Gervin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1204879/full
_version_ 1797803808707837952
author Emilie Willoch Olstad
Emilie Willoch Olstad
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Robert Lyle
Robert Lyle
Robert Lyle
Kristina Gervin
Kristina Gervin
Kristina Gervin
author_facet Emilie Willoch Olstad
Emilie Willoch Olstad
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Robert Lyle
Robert Lyle
Robert Lyle
Kristina Gervin
Kristina Gervin
Kristina Gervin
author_sort Emilie Willoch Olstad
collection DOAJ
description Pharmacoepigenetic studies are important to understand the mechanisms through which medications influence the developing fetus. For instance, we and others have reported associations between prenatal paracetamol exposure and offspring DNA methylation (DNAm). Additionally, folic acid (FA) intake during pregnancy has been associated with DNAm in genes linked to developmental abnormalities. In this study, we aimed to: (i) expand on our previous findings showing differential DNAm associated with long-term prenatal paracetamol exposure in offspring with attention-deficit/hyperactivity disorder (ADHD), and (ii) examine if there is an interaction effect of FA and paracetamol on DNAm in children with ADHD. We used data from the Norwegian Mother, Father and Child Cohort Study (MoBa) and the Medical Birth Registry of Norway (MBRN). We did not identify any impact of paracetamol or any interaction effect of paracetamol and FA on cord blood DNAm in children with ADHD. Our results contribute to the growing literature on prenatal pharmacoepigenetics, but should be replicated in other cohorts. Replication of pharmacoepigenetic studies is essential to ensure robust findings and to increase the clinical relevance of such studies.
first_indexed 2024-03-13T05:26:37Z
format Article
id doaj.art-97a827b8a7d246449b5bb2438892da37
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-13T05:26:37Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-97a827b8a7d246449b5bb2438892da372023-06-15T05:41:10ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.12048791204879No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorderEmilie Willoch Olstad0Emilie Willoch Olstad1Hedvig Marie Egeland Nordeng2Hedvig Marie Egeland Nordeng3Hedvig Marie Egeland Nordeng4Robert Lyle5Robert Lyle6Robert Lyle7Kristina Gervin8Kristina Gervin9Kristina Gervin10Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayPharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayPharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayDepartment of Child Health and Development, Norwegian Institute of Public Health, Oslo, NorwayPharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, NorwayCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, NorwayPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayPharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, NorwayDepartment of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, NorwayPharmacoepigenetic studies are important to understand the mechanisms through which medications influence the developing fetus. For instance, we and others have reported associations between prenatal paracetamol exposure and offspring DNA methylation (DNAm). Additionally, folic acid (FA) intake during pregnancy has been associated with DNAm in genes linked to developmental abnormalities. In this study, we aimed to: (i) expand on our previous findings showing differential DNAm associated with long-term prenatal paracetamol exposure in offspring with attention-deficit/hyperactivity disorder (ADHD), and (ii) examine if there is an interaction effect of FA and paracetamol on DNAm in children with ADHD. We used data from the Norwegian Mother, Father and Child Cohort Study (MoBa) and the Medical Birth Registry of Norway (MBRN). We did not identify any impact of paracetamol or any interaction effect of paracetamol and FA on cord blood DNAm in children with ADHD. Our results contribute to the growing literature on prenatal pharmacoepigenetics, but should be replicated in other cohorts. Replication of pharmacoepigenetic studies is essential to ensure robust findings and to increase the clinical relevance of such studies.https://www.frontiersin.org/articles/10.3389/fgene.2023.1204879/fullADHD (attention deficit and hyperactivity disorder)DNA methyaltionEWAS, epigenome wide association studyfolic acid (FA)MoBa (norwegian mother and child cohort study)paracetamol
spellingShingle Emilie Willoch Olstad
Emilie Willoch Olstad
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Hedvig Marie Egeland Nordeng
Robert Lyle
Robert Lyle
Robert Lyle
Kristina Gervin
Kristina Gervin
Kristina Gervin
No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
Frontiers in Genetics
ADHD (attention deficit and hyperactivity disorder)
DNA methyaltion
EWAS, epigenome wide association study
folic acid (FA)
MoBa (norwegian mother and child cohort study)
paracetamol
title No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
title_full No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
title_fullStr No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
title_full_unstemmed No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
title_short No impact of prenatal paracetamol and folic acid exposure on cord blood DNA methylation in children with attention-deficit/hyperactivity disorder
title_sort no impact of prenatal paracetamol and folic acid exposure on cord blood dna methylation in children with attention deficit hyperactivity disorder
topic ADHD (attention deficit and hyperactivity disorder)
DNA methyaltion
EWAS, epigenome wide association study
folic acid (FA)
MoBa (norwegian mother and child cohort study)
paracetamol
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1204879/full
work_keys_str_mv AT emiliewillocholstad noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT emiliewillocholstad noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT hedvigmarieegelandnordeng noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT hedvigmarieegelandnordeng noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT hedvigmarieegelandnordeng noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT robertlyle noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT robertlyle noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT robertlyle noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT kristinagervin noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT kristinagervin noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder
AT kristinagervin noimpactofprenatalparacetamolandfolicacidexposureoncordblooddnamethylationinchildrenwithattentiondeficithyperactivitydisorder